Venture Capital

New Commerce Dept. duties on Chinese graphite aim to reshape the U.S. battery industry, but will it secure the supply chain or just raise EV costs?

With a new $12M investment, Lightworks aims to help large firms move AI from pilot to production by solving the critical challenges of safety and compliance.

A new report reveals how open source AI is fueling India's explosive market growth, creating a global talent hub, and tackling deep-seated social challenges.

HealthyGirlKitchen’s Danielle Brown takes center stage at FoodieCon, signaling a new era where digital creators are building multi-million dollar empires.

Tech titans like Micron, NVIDIA, and Applied Materials join forces in a $2.5B alliance to forge India into a global deep tech powerhouse.

Sivers Semiconductors unveils new Ka-band chipsets and antennas, promising seamless, high-speed satellite internet for a rapidly growing global market.

With a bolstered cash runway from recent funding, Inventiva is all-in on its MASH drug, lanifibranor, racing against giants in a multi-billion dollar market.

London-based Resurrect Bio lands $8.1M led by Corteva to scale its AI-driven gene-editing platform, aiming to resurrect natural plant immunity.

A key partnership, backed by the Saskatchewan government, is pioneering advanced DLE technology to unlock Canada's vast lithium brine resources for the EV market.

A new study uses PET-CT scans to track CIT-013, a first-in-class antibody targeting the root cause of inflammation in rheumatoid arthritis and HS.

A new partnership integrates advanced underground storage and compression, aiming to solve critical bottlenecks and accelerate green hydrogen adoption.

Amidst global supply chain chaos, SEKO Logistics posts a +71 NPS, far surpassing industry averages. Here’s how they turned service into a science.

Heytea's Eaton Centre lab, a collaboration with Chef Susur Lee, unveils caviar-infused tea, signaling a new front in Canada's beverage wars.

A new end-to-end marketing platform uses massive data and AI to help home builders pinpoint in-market buyers and navigate a complex, shifting market.

A new genomics tracker reveals the fragmented adoption of precision cancer care across the EU-5, highlighting critical barriers and strategic opportunities.

Acurx Pharmaceuticals preps for pivotal Phase 3 trials for its novel C. diff antibiotic, Ibezapolstat, with global regulatory alignment in place.

A new AI search platform promises to decode complex zoning and accelerate land deals, transforming a multi-trillion dollar industry long slowed by manual work.

Paris-based Doctrine acquires Spain's Maite.ai, accelerating its M&A strategy to build a sovereign European alternative to global tech giants.

Zemcelpro® gains key reimbursement status, offering immediate hope and access for German patients with limited options and paving a new path for cell therapy.

A SPAC merger aims to list a key rare earths player on Nasdaq, fueling Europe's quest for mineral independence from China. Here is what's at stake.